T1	PROC 44 94	Estudio de extensión de la eficacia y la seguridad
T2	CHEM 98 104	LTP001
T3	LIVB 108 121	participantes
T4	DISO 126 156	hipertensión arterial pulmonar
#1	AnnotatorNotes T4	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T5	PROC 177 205	Estudio de extensión abierto
T6	PROC 219 274	investigan la eficacia, la seguridad y la tolerabilidad
T7	CHEM 278 284	LTP001
T8	LIVB 288 301	participantes
T9	DISO 306 336	hipertensión arterial pulmonar
#2	AnnotatorNotes T9	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T10	DISO 359 363	Enf.
#3	AnnotatorNotes T10	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T11	ANAT 387 403	vasos sanguíneos
#4	AnnotatorNotes T11	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T12	ANAT 405 414	arterias)
T13	ANAT 422 430	pulmones
#5	AnnotatorNotes T13	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T14	PHYS 446 461	flujo sanguíneo
#6	AnnotatorNotes T14	C0232338; Blood flow; Physiologic Function
T15	PHYS 467 501	presión en las arterias pulmonares
T16	DISO 538 560	insuficiencia cardiaca
#7	AnnotatorNotes T16	C0018801; Heart failure; Disease or Syndrome
T17	DISO 585 615	Hipertensión arterial pulmonar
#8	AnnotatorNotes T17	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T18	PROC 648 684	consentimiento informado por escrito
T19	PROC 729 739	evaluación
#9	AnnotatorNotes T19	C1261322; Evaluation procedure; Health Care Activity
T20	LIVB 744 757	Participantes
T21	Date 762 773	actualmente
T22	DISO 820 823	HAP
#10	AnnotatorNotes T22	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T23	PROC 877 891	procedimientos
T24	PROC 947 958	tratamiento
#11	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	Neg_cue 981 984	sin
T26	Negated 985 1020	cumplir ninguno de los criterios de
T27	PROC 1021 1036	discontinuación
T28	Negated 1021 1036	discontinuación
T29	PROC 1105 1112	visitas
T30	PROC 1140 1151	tratamiento
#12	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	PROC 1169 1182	procedimiento
T32	LIVB 1199 1212	Participantes
T33	Date 1217 1228	actualmente
T34	Neg_cue 1229 1231	no
T35	Negated 1242 1251	signos de
T36	DISO 1242 1248	signos
#13	AnnotatorNotes T36	C0311392; Physical findings; Finding
T37	Neg_cue 1252 1254	no
T38	Negated 1261 1286	respondido al tratamiento
T39	PROC 1275 1286	tratamiento
#14	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T40	LIVB 1307 1319	investigador
#15	AnnotatorNotes T40	C0035173; Research Personnel; Professional or Occupational Group
T41	PROC 1333 1344	tratamiento
#16	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	LIVB 1358 1371	Participantes
T43	LIVB 1392 1404	investigador
#17	AnnotatorNotes T43	C0035173; Research Personnel; Professional or Occupational Group
T44	Speculated 1406 1422	se beneficiarían
T45	PROC 1427 1438	tratamiento
#18	AnnotatorNotes T45	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T46	CHEM 1443 1449	LTP001
T47	Spec_cue 1451 1457	Pueden
T48	Speculated 1468 1473	otros
T49	Speculated 1474 1496	criterios de inclusión
T50	PROC 1514 1523	protocolo
#19	AnnotatorNotes T50	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T51	DISO 1569 1586	hipersensibilidad
#20	AnnotatorNotes T51	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T52	PROC 1590 1601	tratamiento
#21	AnnotatorNotes T52	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T53	PROC 1618 1628	Trasplante
#22	AnnotatorNotes T53	C0040732; Transplantation; Therapeutic or Preventive Procedure
T54	PROC 1631 1656	cirugía de corazón/pulmón
T55	DISO 1684 1693	Deterioro
#23	AnnotatorNotes T55	C0231171; Physical impairment; Finding | C0684336; Impaired health; Finding | C1265875; Disintegration (morphologic abnormality); Acquired Abnormality
T56	Duration 1702 1709	crónico
T57	Neg_cue 1711 1716	salvo
T58	DISO 1720 1726	disnea
#24	AnnotatorNotes T58	C0013404; Dyspnea; Sign or Symptom
T59	Negated 1720 1726	disnea
T60	PROC 1864 1878	procedimientos
T61	PROC 1899 1903	6MWT
T62	DISO 1913 1928	angina de pecho
#25	AnnotatorNotes T62	C0002962; Angina Pectoris; Sign or Symptom
T63	DISO 1930 1942	claudicación
#26	AnnotatorNotes T63	C0231176; Acute failure; Pathologic Function | C1456822; Claudication (finding); Finding
T64	DISO 1944 1972	trastorno musculoesquelético
#27	AnnotatorNotes T64	C0026857; Musculoskeletal Diseases; Disease or Syndrome
T65	DEVI 1988 2009	dispositivos de ayuda
#28	AnnotatorNotes T65	C0036605; Self-Help Devices; Medical Device
T66	PHYS 2015 2022	caminar
T67	PROC 2028 2043	Discontinuación
T68	CHEM 2059 2066	fármaco
#29	AnnotatorNotes T68	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T69	DISO 2112 2121	toxicidad
#30	AnnotatorNotes T69	C0600688; Toxic effect; Injury or Poisoning
T70	DISO 2124 2151	progresión de la enfermedad
#31	AnnotatorNotes T70	C0242656; Disease Progression; Pathologic Function
T71	PROC 2175 2189	procedimientos
T72	Neg_cue 2203 2215	retirada del
T73	PROC 2216 2230	consentimiento
T74	Negated 2216 2230	consentimiento
T75	Spec_cue 2256 2262	Pueden
T76	Speculated 2273 2278	otros
T77	Speculated 2279 2301	criterios de exclusión
T78	PROC 2319 2328	protocolo
#32	AnnotatorNotes T78	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
